Lavender Sky Health Review

Our assessment

Lavender Sky Health prices the pharmacy as well as the drug: eight monthly lanes across six named compounding pharmacies, each with its own figure. Nobody else in this comparison names as many. Against that, it publishes no state list of its own, says coverage is set by each pharmacy separately, and has a governing-law clause that names no state at all. And almost every preparation it sells is a combination product rather than the plain drug.

It prices the pharmacy, which almost nobody else does

The usual shape of this category is one price per drug and a pharmacy nobody names. Ninety-four of the four hundred and twenty sellers here name a pharmacy at all, and of those, two publish a separate figure per pharmacy. This is one; the other is TOM Weight Loss, whose à la carte lane prices each dose across five named pharmacies but which serves two states.

Six pharmacies carry monthly plans here. The page names each one, prints the formulation it prepares, attaches a beyond-use window and gives every lane its own figure. So you can see what your choice of pharmacy actually costs, a question all but one of the rest of this field won't let you ask.

Beyond the monthly plans it names more than a dozen further compounding pharmacies across the catalog, which is the longest such list here by a wide margin.

Read the ingredient list, not just the drug name

Seven of the eight monthly lanes are combination preparations. The GLP-1 is compounded with a vitamin, an amino acid or a related additive, and the product name says so. Only one lane is the plain drug.

That is not a footnote. A compounded semaglutide with an added B vitamin is not the same product as a compounded semaglutide, and neither is the same as the FDA-approved finished drug. Compare these figures against a single-ingredient preparation elsewhere and you are comparing different things.

The dose matters too. Every figure here is the starter tier of its section, and the higher doses in each section cost more. The qualifier beside each price names those higher figures, so you can see the ladder before you open the page.

The prices are there, behind a toggle

The whole price table sits inside collapsed accordions. Land on the page and there is not a single figure on it. Open the toggles and the full table comes up, and the page grows from a few thousand characters to more than forty thousand.

The figures are published, and clicking is all it takes. But anyone who doesn't click sees a pricing page with no prices on it, which is a real cost and a fair reason people walk away thinking a seller is hiding its numbers.

One more condition sits at page level: a monthly plan is typically dispensed as a single vial and is meant to be used within about five weeks. Most of this field never states a supply term at all.

A membership scoped to the brand-name lane

The pricing page prints a standard treatment plan at a monthly fee plus the cost of medication, twice, in consecutive lines, one of them naming the brand-name version. Right after it, the page says that if you and your provider choose a branded product, you'll be invoiced for it.

The compounded monthly plans are quoted differently: each as a total for one month's supply, with shipping and supplies included. Forty-six of the four hundred and twenty sellers here bill a membership apart from the medication.

So ask one short question before you buy. Does the monthly figure for the pharmacy you picked already include everything, or does the standard-plan fee sit underneath it? The page states both structures and never says which applies to which purchase.

Where the disclosure stops

There is no state list, and the company says why: each pharmacy is licensed to ship to its own set of states, and it points you at a separate per-pharmacy coverage page. That is an honest reason, and it still means the priced page can't tell you whether you can buy.

The governing-law clause names no state either. It says the terms are governed by the laws of the state applicable to the patient's care, which is not a forum you can identify in advance.

No individual prescribing clinician is named anywhere. The company, its address and its privacy and notice documents are all published, so the corporate disclosure is fine. It is the clinical one that stops.